Peak HumanDatabase
    All Supplements
    Supplement

    Boswellia Serrata (AKBA)New

    Supplement
    Joint Support
    4/10 Evidence

    A resin extract standardized to boswellic acids, particularly acetyl-11-keto-beta-boswellic acid (AKBA), used for osteoarthritis pain and as a botanical anti-inflammatory. Small to moderate pain benefits are seen in knee osteoarthritis, though trials are short and products are not interchangeable.

    Mechanism of Action

    Boswellic acids, especially AKBA, inhibit 5-lipoxygenase (reducing leukotriene synthesis), and appear to reduce NF-kB signaling and matrix metalloproteinase activity. Unlike NSAIDs, they do not substantially inhibit cyclooxygenase, which may explain better GI tolerability. Absorption of boswellic acids is poor; formulations with phospholipid, lecithin or curcumin are used to improve bioavailability.

    Dosing Protocol

    Recommended

    300mg per day of extract standardized to boswellic acids (e.g. 100-250 mg of AKBA-enriched extract, or 300-500 mg of 65% boswellic acid extract, up to three times daily)

    Standard starting dose based on research

    Therapeutic Range

    100

    Minimum

    to

    1000

    Maximum

    mg per day of extract standardized to boswellic acids (e.g. 100-250 mg of AKBA-enriched extract, or 300-500 mg of 65% boswellic acid extract, up to three times daily)

    With meals, ideally with some fat to improve absorption

    Cycling Protocol

    Trials run 1-6 months; reassess benefit at 8-12 weeks and use the lowest effective dose

    Dosages are general guidelines. Individual requirements vary based on body weight, health status, and specific goals. Start with lower doses and adjust based on response.

    Benefits

    Primary Benefits

    • Reduced knee osteoarthritis pain and improved function
    • Anti-inflammatory support with a favorable GI tolerability profile

    Secondary Benefits

    Possible benefit in inflammatory bowel conditions (small trials)
    Possible benefit in asthma and respiratory inflammation (limited)

    Safety Information

    Contraindications

    Do not use if any of the following apply:

    • •Pregnancy (possible uterine stimulation) and breastfeeding
    • •Allergy to Burseraceae resins
    • •Active peptic ulcer or severe GI disease — use clinician guidance

    Drug/Supplement Interactions

    May interact with the following. Consult a healthcare provider before combining:

    NSAIDs — possible additive effect; clinical significance unclear
    CYP3A4 and CYP2C9 substrates — boswellic acids may alter drug levels
    Anticoagulants — theoretical bleeding risk, monitor
    Immunosuppressants — theoretical interaction

    Potential Side Effects

    Some users may experience:

    Mild GI upset, nausea or diarrhea
    Heartburn
    Skin rash
    Rare liver enzyme elevation in case reports with multi-ingredient products

    This is not a complete list of interactions or side effects. Individual responses vary. Always start with the lowest effective dose and monitor your response. Report any adverse effects to your healthcare provider.

    Quality Markers

    Look for these specific quality indicators when sourcing this compound:

    • Boswellia serrata (not frereana or carterii) with stated boswellic acid or AKBA percentage
    • Branded, trial-tested extracts (e.g. 5-Loxin, Aflapin) where possible
    • Third-party tested

    Trusted Certifications

    NSF Certified
    USP Verified
    GMP Certified
    ConsumerLab Approved

    Note: Supplement quality varies dramatically between brands. Cheap supplements often contain fillers, incorrect doses, or contaminants. Investing in quality products from reputable manufacturers is essential for safety and efficacy.

    Evidence Profile

    Evidence Score

    4/10

    Emerging/Anecdotal

    Limited clinical data, primarily mechanistic studies or user reports

    Classification:
    Moderate — a 2024 meta-analysis summarized by Examine (9 RCTs, 712 adults, trials of about 1-6 months) reported reduced pain on VAS and WOMAC scales versus control, and a 2020 meta-analysis (BMC Complementary Medicine and Therapies; 7 trials, 545 patients) found pain, stiffness and function improvements. A Cochrane review on oral herbal therapies for osteoarthritis was more cautious, noting only two small studies of enriched extract with wide confidence intervals. Trials are small, short, vary by extract, and are often manufacturer-linked. I could see only the summary of the 2024 meta-analysis and not the full paper. Scored Emerging/Moderate (4). Evidence

    Evidence Scale

    8-10

    Strong

    5-7

    Moderate

    1-4

    Emerging

    PHS
    671
    / 1000
    T3
    Longevity Operator

    Sample member

    Longevity Operator

    The Peak Human Score · PHS v1

    One number for your longevity journey.

    FICO for credit. PHS for longevity. Eight biological domains collapsed into one provable score — intuitive at a glance, rigorous underneath.

    • Metabolic
    • Hormonal
    • Cardiovascular
    • Brain / Cognitive
    • Sleep
    • Musculoskeletal
    • Gut
    • Immunity / Inflammation
    See your Peak Human Score How it works